217 related articles for article (PubMed ID: 7581949)
1. Subcutaneous octreotide treatment of a growth hormone-releasing hormone-secreting bronchial carcinoid: superiority of continuous versus intermittent administration to control hormonal secretion.
Lefebvre S; De Paepe L; Abs R; Rahier J; Selvais P; Maiter D
Eur J Endocrinol; 1995 Sep; 133(3):320-4. PubMed ID: 7581949
[TBL] [Abstract][Full Text] [Related]
2. Ectopic growth hormone-releasing hormone secretion by a bronchial carcinoid tumor: clinical experience following tumor resection and long-acting octreotide therapy.
Butler PW; Cochran CS; Merino MJ; Nguyen DM; Schrump DS; Gorden P
Pituitary; 2012 Jun; 15(2):260-5. PubMed ID: 20379782
[TBL] [Abstract][Full Text] [Related]
3. Ectopic growth hormone-releasing hormone secretion by a metastatic bronchial carcinoid tumor: a case with a non hypophysial intracranial tumor that shrank during long acting octreotide treatment.
Fainstein Day P; Frohman L; Garcia Rivello H; Reubi JC; Sevlever G; Glerean M; Fernandez Gianotti T; Pietrani M; Rabadan A; Racioppi S; Bidlingmaier M
Pituitary; 2007; 10(3):311-9. PubMed ID: 17373589
[TBL] [Abstract][Full Text] [Related]
4. Acromegaly due to ectopic growth hormone-releasing hormone secretion by a bronchial carcinoid tumour. Dynamic hormonal responses to various stimuli.
Glikson M; Gil-Ad I; Galun E; Dresner R; Zilberman S; Halperin Y; Okon E; Laron Z; Rubinow A
Acta Endocrinol (Copenh); 1991 Oct; 125(4):366-71. PubMed ID: 1683501
[TBL] [Abstract][Full Text] [Related]
5. Somatotroph hyperplasia without pituitary adenoma associated with a long standing growth hormone-releasing hormone-producing bronchial carcinoid.
Ezzat S; Asa SL; Stefaneanu L; Whittom R; Smyth HS; Horvath E; Kovacs K; Frohman LA
J Clin Endocrinol Metab; 1994 Mar; 78(3):555-60. PubMed ID: 8126126
[TBL] [Abstract][Full Text] [Related]
6. Medical management of acromegaly due to ectopic production of growth hormone-releasing hormone by a carcinoid tumor.
Melmed S; Ziel FH; Braunstein GD; Downs T; Frohman LA
J Clin Endocrinol Metab; 1988 Aug; 67(2):395-9. PubMed ID: 2899089
[TBL] [Abstract][Full Text] [Related]
7. The pulsatile GH secretion in acromegaly: hypothalamic or pituitary origin?
Riedel M; Günther T; von zur Mühlen A; Brabant G
Clin Endocrinol (Oxf); 1992 Sep; 37(3):233-9. PubMed ID: 1358484
[TBL] [Abstract][Full Text] [Related]
8. Octreotide suppresses both growth hormone (GH) and GH-releasing hormone (GHRH) in acromegaly due to ectopic GHRH secretion.
Moller DE; Moses AC; Jones K; Thorner MO; Vance ML
J Clin Endocrinol Metab; 1989 Feb; 68(2):499-504. PubMed ID: 2493033
[TBL] [Abstract][Full Text] [Related]
9. Acromegaly and Cushing's syndrome due to ectopic production of GHRH and ACTH by a thymic carcinoid tumour: in vitro responses to GHRH and GHRP-6.
Jansson JO; Svensson J; Bengtsson BA; Frohman LA; Ahlman H; Wängberg B; Nilsson O; Nilsson M
Clin Endocrinol (Oxf); 1998 Feb; 48(2):243-50. PubMed ID: 9579239
[TBL] [Abstract][Full Text] [Related]
10. Octreotide as primary therapy for acromegaly.
Newman CB; Melmed S; George A; Torigian D; Duhaney M; Snyder P; Young W; Klibanski A; Molitch ME; Gagel R; Sheeler L; Cook D; Malarkey W; Jackson I; Vance ML; Barkan A; Frohman L; Kleinberg DL
J Clin Endocrinol Metab; 1998 Sep; 83(9):3034-40. PubMed ID: 9745397
[TBL] [Abstract][Full Text] [Related]
11. Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects.
Gola M; Doga M; Bonadonna S; Mazziotti G; Vescovi PP; Giustina A
Pituitary; 2006; 9(3):221-9. PubMed ID: 17036195
[TBL] [Abstract][Full Text] [Related]
12. Effects of somatostatin analogs on a growth hormone-releasing hormone secreting bronchial carcinoid, in vivo and in vitro studies.
van Hoek M; Hofland LJ; de Rijke YB; van Nederveen FH; de Krijger RR; van Koetsveld PM; Lamberts SW; van der Lely AJ; de Herder WW; Feelders RA
J Clin Endocrinol Metab; 2009 Feb; 94(2):428-33. PubMed ID: 19017754
[TBL] [Abstract][Full Text] [Related]
13. Acromegaly and hyperprolactinemia in a patient with polyostotic fibrous dysplasia: dynamic endocrine studies and treatment with the somatostatin analogue octreotide.
Garcia MB; Koppeschaar HP; Lips CJ; Thijssen JH; Krenning EP
J Endocrinol Invest; 1994 Jan; 17(1):59-65. PubMed ID: 7911814
[TBL] [Abstract][Full Text] [Related]
14. Ectopic growth hormone-releasing hormone secretion by a neuroendocrine tumor causing acromegaly: long-term follow-up results.
Colak Ozbey N; Kapran Y; Bozbora A; Erbil Y; Tascioglu C; Asa SL
Endocr Pathol; 2009; 20(2):127-32. PubMed ID: 19301154
[TBL] [Abstract][Full Text] [Related]
15. Acromegaly due to a growth hormone-releasing hormone-secreting bronchial carcinoid tumor: further information on the abnormal responsiveness of the somatotroph cells and their recovery after successful treatment.
Boizel R; Halimi S; Labat F; Cohen R; Bachelot I
J Clin Endocrinol Metab; 1987 Feb; 64(2):304-8. PubMed ID: 3098773
[TBL] [Abstract][Full Text] [Related]
16. Acromegaly due to GHRH-secreting large bronchial carcinoid. Complete recovery following tumor surgery.
Bolanowski M; Schopohl J; Marciniak M; Rzeszutko M; Zatonska K; Daroszewski J; Milewicz A; Malczewska J; Badowski R
Exp Clin Endocrinol Diabetes; 2002 Jun; 110(4):188-92. PubMed ID: 12058343
[TBL] [Abstract][Full Text] [Related]
17. Long-acting lanreotide induces clinical and biochemical remission of acromegaly caused by disseminated growth hormone-releasing hormone-secreting carcinoid.
Drange MR; Melmed S
J Clin Endocrinol Metab; 1998 Sep; 83(9):3104-9. PubMed ID: 9745411
[TBL] [Abstract][Full Text] [Related]
18. Acromegaly caused by a growth hormone-releasing hormone secreting carcinoid tumour of the lung: the effect of octreotide treatment.
de Jager CM; de Heide LJ; van den Berg G; Wolthuis A; van Schelven WD
Neth J Med; 2007; 65(7):263-6. PubMed ID: 17656813
[TBL] [Abstract][Full Text] [Related]
19. Acromegaly caused by a growth hormone-releasing hormone-secreting carcinoid tumor: case report.
Altstadt TJ; Azzarelli B; Bevering C; Edmondson J; Nelson PB
Neurosurgery; 2002 Jun; 50(6):1356-9; discussion 1360. PubMed ID: 12015856
[TBL] [Abstract][Full Text] [Related]
20. [Five year remission of GHRH secreting bronchial neuroendocrine tumor with symptoms of acromegaly. Utility of chromogranin A in the monitoring of the disease].
Bolanowski M; Kos-Kudła B; Rzeszutko M; Marciniak M; Zatońska K
Endokrynol Pol; 2006; 57(1):32-6. PubMed ID: 16575760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
